Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Compound Theophylline and Ephedrine Tablets

Approved

化学药品

Compound Theophylline and Ephedrine Tablets

吉林东懿制药有限公司🇨🇳 National Medical Products Administration

Approval Date: May 31, 2003
Approval ID: 7zxQSwq8q6E
Company: 吉林东懿制药有限公司
Type: 化学药品

Approval Details

Approval Id: 7zxQSwq8q6E
Approval Number: 国药准字H22025981
Generic Name: 复方茶碱麻黄碱片
Generic Name En: Compound Theophylline and Ephedrine Tablets
Drug Type: 化学药品
Strength: 复方
Reg Date: 2003-05-31
Company Name: 吉林东懿制药有限公司
Production Company Address: 四平市铁东区团结路117号
Company Detail Path: /organization/ji-lin-dong-yi-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

May 31, 2003

Approval ID

7zxQSwq8q6E

Type

化学药品

Back to NMPA Approvals

复方茶碱麻黄碱片 - NMPA Drug Approval Details